ArticleBiomedical chromatography : BMC2026
Development and Validation of Isocratic RP-UHPLC Method for Assay of Fenofibrate Tablet.
Article in Biomedical chromatography : BMC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A method developed and validated for the assay of fenofibrate in tablet dosage form by isocratic RP-UHPLC-UV technique has been rapid and precise. The material was chromatographed on Shim-pack Velox C18 column (50 × 2.1 mm, 1.8 μm) at 40°C with isocratic mobile phase: acidified water/acetonitrile (60:40, v/v) at 0.4 mL/min and at a detection wavelength of 286 nm. The total run time was 6.0 min and fenofibrate eluted at ~2.4 min. The method was linear over 10-90 μg/mL (r
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.